These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3301155)

  • 1. Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertension.
    Baba T; Ishizaki T; Murabayashi S; Aoyagi K; Tamasawa N; Takebe K
    Clin Pharmacol Ther; 1987 Aug; 42(2):232-9. PubMed ID: 3301155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension.
    Baba T; Boku A; Ishizaki T; Sone K; Takebe K
    Am Heart J; 1986 Mar; 111(3):552-7. PubMed ID: 3953366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of nicardipine, a calcium entry blocker, in hypertensive type II diabetic patients with nephropathy.
    Baba T; Ishizaki T; Ido Y; Aoyagi K; Murabayashi S; Takebe K
    Diabetes; 1986 Nov; 35(11):1206-14. PubMed ID: 3530849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
    Lucarini AR; Salvetti A
    J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy.
    Baba T; Tomiyama T; Murabayashi S; Takebe K
    Eur J Clin Pharmacol; 1990; 38(5):425-9. PubMed ID: 2379527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic effects of a new calcium inhibitor, nicardipine, on renal hemodynamics in hypertension.
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guedon J
    J Cardiovasc Pharmacol; 1986; 8(5):892-7. PubMed ID: 2429087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T; Murabayashi S; Takebe K
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nicardipine on sodium and calcium metabolism in hypertensive patients: a chronic study.
    Soro S; Cocca A; Pasanisi F; Tommaselli A; de Simone G; Costantino G; Ferrara LA
    J Clin Pharmacol; 1990 Feb; 30(2):133-7. PubMed ID: 2179277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of nicardipine in essential hypertension: differences between acute and chronic therapy.
    Smith SA; Rafiqi EI; Gardener EG; Young MA; Littler WA
    J Hypertens; 1987 Dec; 5(6):693-7. PubMed ID: 3429869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicardipine on blood pressure and renal function in elderly hypertensive patients with renal dysfunction.
    Saruta T
    Am Heart J; 1989 Jan; 117(1):243-9. PubMed ID: 2643283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism.
    Veglio F; Pinna G; Bisbocci D; Rabbia F; Piras D; Chiandussi L
    J Hum Hypertens; 1990 Oct; 4(5):579-82. PubMed ID: 2283648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a calcium-entry blocker, nicardipine, on intrarenal hemodynamics in essential hypertension.
    Kimura G; Deguchi F; Kojima S; Ashida T; Yoshimi H; Abe H; Kawano Y; Yoshida K; Kawamura M; Imanishi M
    Am J Kidney Dis; 1991 Jan; 17(1):47-54. PubMed ID: 1986570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute effect of nicardipine on the renin-angiotensin-aldosterone system in salt-sensitive essential hypertension.
    Wu KD; Hsieh BS; Chu TS; Yen TS
    Clin Exp Hypertens; 1993 Jan; 15(1):185-96. PubMed ID: 8467312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sustained-release nicardipine on regression of left ventricular hypertrophy in systemic hypertension.
    Dittrich HC; Adler J; Ong J; Reitman M; Weber M; Ziegler M
    Am J Cardiol; 1992 Jun; 69(19):1559-64. PubMed ID: 1534642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.
    Baba T; Murabayashi S; Aoyagi K; Ishizaki T
    Eur J Clin Pharmacol; 1988; 35(1):9-15. PubMed ID: 2905992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of nicardipine on blood pressure, renal function and plasma aldosterone in normotensive volunteers.
    van Schaik BA; Hene RJ; Geyskes GG
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):88S-94S. PubMed ID: 3896284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic and renal hemodynamic effects of nicardipine in essential hypertension.
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Kidney Int Suppl; 1988 Sep; 25():S184-6. PubMed ID: 3054236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.